Exploring the potential of imidazolium methacrylate crosslinking with resorcinol dimethacrylate for drug delivery systems

Jacianny M. S. Bezerra,Maria J. S. Lima,Dayane K. D. N. Santos,Larissa G. Maciel,Severino Alves‐Jr,Janaína V. dos Anjos
DOI: https://doi.org/10.1002/app.56425
IF: 3
2024-11-01
Journal of Applied Polymer Science
Abstract:Imidazolium methacrylate crosslinking with resorcinol dimethacrylate for new drug delivery systems with thermal stability up to 170°C. This novel photopolymerizable biocompatible hydrogel is swellable up to 5 times its size in 48 h, showing a drug release profile similar to the swelling profile, indicating a direct relationship between medium hydration and drug release for this resin. Drug implants offer an alternative for controlling drug release and maintaining plasma levels of a specific drug. In this study, we explored the potential of imidazolium methacrylate crosslinking with resorcinol methacrylate to develop implantable drug delivery systems. The focus was on fabricating a photopolymerizable material based on a novel biocompatible hydrogel for implantable drug delivery systems with dexamethasone, a widely used corticosteroid with potent anti‐inflammatory properties, chosen as the model drug. The experimental section detailed the synthesis of polymerizable units, resin preparation, and resin choice for further tests using a 23 factorial design, printing conditions, material characterization, biocompatibility, and dexamethasone release tests. Our findings shed light on the potential of this novel approach for creating targeted drug delivery systems, holding promise for improving therapeutic outcomes, and reducing side effects associated with systemic long‐term drug administration.
polymer science
What problem does this paper attempt to address?